SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010179
Filing Date
2015-11-09
Accepted
2015-11-09 16:33:35
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptla-10q_20150930.htm 10-Q 1836490
2 EX-10.5 ptla-ex105_49.htm EX-10.5 26734
3 EX-31.1 ptla-ex311_6.htm EX-31.1 9664
4 EX-31.2 ptla-ex312_7.htm EX-31.2 9690
5 EX-32.1 ptla-ex321_9.htm EX-32.1 8538
  Complete submission text file 0001564590-15-010179.txt   6147675

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptla-20150930.xml EX-101.INS 1380464
7 XBRL TAXONOMY EXTENSION SCHEMA ptla-20150930.xsd EX-101.SCH 41409
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20150930_cal.xml EX-101.CAL 32886
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20150930_def.xml EX-101.DEF 128229
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20150930_lab.xml EX-101.LAB 303312
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20150930_pre.xml EX-101.PRE 236127
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 151216138
SIC: 2834 Pharmaceutical Preparations